G
Genosys develops AI-driven models trained on extensive sequence datasets to optimize gene expression architecture for biotechnology applications. The platform focuses on boosting biologics production efficiency for CDMOs and innovators while also generating tailored oligonucleotide sequences for advanced therapeutics. This intelligent approach aims to create smarter, more efficient solutions for biologic drug manufacturing.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Genosys develops AI-driven models trained on extensive DNA sequence datasets to enhance gene expression architecture. The platform optimizes gene expression for biomanufacturing, helping CDMOs and biotech firms boost biologics production yields. Additionally, the company designs tailored oligonucleotide sequences for precise control over gene activity in advanced therapeutics.